Evaluation of the First Commercial Hepcidin ELISA for the Differential Diagnosis of Anemia of Chronic Disease and Iron Deficiency Anemia in Hospitalized Geriatric Patients

<table>Serum hepcidin levels in 26 healthy controls (cont), 28 patients with anemia of chronic disease (ACD) and 11 patients with iron deficiency anemia (IDA).</table>

International Scholarly Research Notices

fig1

Figure 1

Figure 1: Evaluation of the First Commercial Hepcidin ELISA for the Differential Diagnosis of Anemia of Chronic Disease and Iron Deficiency Anemia in Hospitalized Geriatric Patients 

Figure 1 | Evaluation of the First Commercial Hepcidin ELISA for the Differential Diagnosis of Anemia of Chronic Disease and Iron Deficiency Anemia in Hospitalized Geriatric Patients 